cannaQIX® 10

cannaQIX® is the first and unique standardized nutraceutical containing organic full plant CBD hemp extract, vitamins and zinc aiming to reduce stress and to support psychological and nervous functions.

What is cannaQIX®?

cannaQIX® is the first and unique nutraceutical composed according to the synergistic formula of organic full plant CBD hemp extract, hemp seed oil, the vitamins niacin, B12, B6, C and zinc, delivered in a lozenge, in a sugar-free formulation.

cannaQIX® supports the psychological balance.

The vitamins and zinc enrichment support the reduction of stress and enhance the psyche and nervous functions.

Niacin and vitamins B6, B12 and C contribute to normal psychological function, to the reduction of tiredness and fatigue and to the normal function of the nervous system. Zinc contributes to normal cognitive function.

The innovative buccal delivery system provides rapid absorption and high bioavailability.

cannaQIX® is well tolerated, pleasant in taste, containing standardized full plant CBD hemp extract with no psychotropic effect. (THC content ≤ 0.00084% (=traces only) of finished product).

cannaQIX® is the first and unique standardized nutraceutical containing organic full plant CBD hemp extract, vitamins and zinc aiming to reduce stress and to support psychological and nervous functions.

Proprietary buccal delivery system

Use of the buccal delivery system: fast absorption and high bioavailability (Huestis 2007).
The buccal mucosa offers a near ideal non-invasive portal through which natural products can enter directly into the blood stream (Huestis 2007; Ko et al. 2016).
Among the challenges of formulating phytocannabinoids as supplements or medicines are their lipophilicity and slow absorption (Russo 2016).
When delivered orally either in tablet or capsule, the bioavailability of CBD is very low because of substantial first-pass effect in the liver (Huestis 2007; Ko et al. 2016). More specifically, bioavailability of oral CBD in humans was found to be around 3-6%. This provides a further support for a significant first-pass effect (Zhornitsky and Potvin 2012). Smoking/vaporizing delivers somehow higher concentration, but usually judged to be too rapid and this delivery form is often not suited to a therapeutic context. 

Within the oral mucosal cavity, the buccal regions offer an attractive route of administration, because the bioavailability is higher and ranges from 15 to 25% (Bartlett et al. 2012). 

Directions of use

Adults: Dissolve one lozenge slowly in the mouth. 1 to 3 lozenges per day.

In Switzerland: 1 to 2 lozenges per day.

cannaQIX® lozenges can be taken daily. Regular intake aims to reduce the stress. Do not exceed the recommended dose. Keep in the original packaging. Do not use cannaQIX® after the “best before” date on the pack. Excessive consumption may produce a laxative effect.

Intake of cannaQIX®

  • Split off one QIX from the blister
  • Lift and pull the QIX foil from a corner
  • Let QIX slowly melt in the mouth

Commercial Partner in Switzerland

Doetsch Grether AG, Basel

Commercial Partner in the Netherlands

Mediphos OTC Consumer Health BV, Renkum

CRESO Pharma Switzerland uses cookies to optimise and improve the website, as well as enable the availability of certain functions. By continuing to use this website, you agree to our use of cookies. For further information on how we use cookies, please click here.